(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 55.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Dbv Technologies Sa's revenue in 2025 is $4,151,000.On average, 1 Wall Street analysts forecast DBVT's revenue for 2025 to be $742,262,886, with the lowest DBVT revenue forecast at $742,262,886, and the highest DBVT revenue forecast at $742,262,886. On average, 1 Wall Street analysts forecast DBVT's revenue for 2026 to be $816,215,277, with the lowest DBVT revenue forecast at $816,215,277, and the highest DBVT revenue forecast at $816,215,277.
In 2027, DBVT is forecast to generate $2,393,866,283 in revenue, with the lowest revenue forecast at $2,393,866,283 and the highest revenue forecast at $2,393,866,283.